Tenaya Therapeutics, Inc. (TNYA) Reports In-Line Q4 EPS

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q4 EPS of ($0.12), in-line with the analyst estimate of ($0.12).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• The OLB Group Reports Second Quarter 2026 Results and Completes Company-Wide Transition to AI-Assisted Software Development
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)